Revision: March 20, 2024, 8:57 p.m.
Rep. Hunt, Ches. 14
March 20, 2024
2024-1243h
09/05
Amendment to HB 1365
Amend RSA 318:47-dd, IV as inserted by section 1 of the bill by replacing it with the following:
IV. When a pharmacist dispenses an interchangeable biological product for the prescribed biological product, the pharmacist or his or her designee shall inform the patient and the prescriber.
Amend RSA 318:47-dd, VII as inserted by section 1 of the bill by replacing it with the following:
VII. The label of all biological products dispensed by a pharmacist shall include the proper name and the name of the manufacturer of the product.
VIII. A pharmacist shall not substitute an interchangeable biological product that results in an increased cost to the patient.
2024-1243h
AMENDED ANALYSIS
This bill allows for the substitution by a pharmacist of an interchangeable biological product for another interchangeable biological product, and prohibits the substitution of an interchangeable biological product if the substitution would result in an increase in cost to the patient.